Cardioprotective Effects of Alpha-Lipoic Acid on Myocardial Reperfusion Injury: Suppression of Reactive Oxygen Species Generation and Activation of Mitogen-Activated Protein Kinase by Oh, Seok Kyu et al.
 
 
  359
ORIGINAL ARTICLE 
DOI 10.4070 / kcj.2009.39.9.359 
Print ISSN 1738-5520 / On-line ISSN 1738-5555
Copyright ⓒ 2009 The Korean Society of Cardiology
 
Cardioprotective Effects of Alpha-Lipoic Acid on Myocardial 
Reperfusion Injury: Suppression of Reactive Oxygen Species 
Generation and Activation of Mitogen-Activated Protein Kinase 
 
Seok Kyu Oh, MD
1, Kyeong Ho Yun, MD
1, Nam Jin Yoo, MD
1, Nam-Ho Kim, MD
1, 
Min-Sun Kim, MD
2, Byung-Rim Park, MD
2 and Jin-Won Jeong, MD
1 
1Division of Cardiology, Departments of Internal Medicine and 
2Physiology, Wonkwang University School of Medicine, Iksan, Korea 
 
ABSTRACT 
Background and Objectives: Reactive oxygen species (ROS) and mitogen-activated protein (MAP) kinase play an 
important role in the development of myocardial reperfusion injury. In this study, we examined whether treatment 
with alpha-lipoic acid (ALA) before reperfusion could prevent myocardial reperfusion injury in vivo. Materials 
and Methods: Sprague-Dawley rats were subjected to a 45-minute left anterior descending coronary artery ligation 
followed by 45- or 10-minute reperfusion. ALA was administered 10 minutes prior to reperfusion. The infarct size 
ratio of the infarct area to the ischemic area at risk, was measured based on 10, 25, 50, and 100 mg/kg of ALA, 
with propidium iodide (PI) fluorescence. Apoptosis was evaluated by TdT-mediated dUDP nick end labeling 
(TUNEL) staining. The generation of intracellular ROS was evaluated using the fluorogenic probe, dichlorodihy-
drofluorescein diacetate (CM-H2DCFDA). Western blot analysis was performed for MAP kinase (pERK 1/2 and 
pJNK 1/2) activity. Results: The infarct size, according to ALA dose, was significantly suppressed 29.1% with ALA 
25 mg/kg (p<0.0001), 41.5% with 50 mg/kg (p<0.05), and 41.4% with 100 mg/kg (p<0.05) compared to the con-
trols (54.3%). However, the results were not significantly different with 47.2% of the ALA 10 mg/kg (p=0.192). A 
few apoptotic nucleoli were detected in the ALA 25 mg/kg group, but were frequently detected in the control group. 
The ROS generation was significantly suppressed (p<0.0001), the activity of pERK 1/2 was significantly increased 
(p<0.05) and the activity of pJNK 1/2 was significantly decreased (p<0.05) in the ALA 25 mg/kg group com-
pared to the controls. Conclusion: The results of this study suggested that adequate doses of ALA before reper-
fusion was effective for the prevention of myocardial reperfusion injury in vivo. This cardioprotective activity of ALA 
might be associated with an anti-apoptotic effect of ALA via suppression of ROS generation, increase of pERK 
1/2 and decrease of pJNK 1/2 activity. (Korean Circ J 2009;39:359-366) 
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Introduction 
 
Following acute myocardial infarction, re-establishing 
coronary blood flow with the rapid use of reperfusion 
strategies such as thrombolysis or primary coronary 
intervention is essential to salvage viable myocardium. 
However, paradoxically, the process of reperfusion can 
itself result in myocyte death, a phenomenon referred to 
as “lethal reperfusion injury”.
1) Apoptosis and necrosis 
are the two major distinct types of cell death of cardio-
myocytes that have been associated with ischemia and 
reperfusion. Particularly, apoptosis-induced myocyte dea-
th is thought to play an important role during the early 
stages of reperfusion.
2-4) 
The exact mechanisms underlying myocardial reperfu-
sion injury are not known. However, reactive oxygen spe-
cies (ROS) are formed in excessive amounts within the first 
few minutes following reperfusion and are considered 
important to myocardial reperfusion injury.
5) In addition, 
excessive ROS during the early stages of reperfusion in-
creases the activity of mitogen-activated protein (MAP) 
kinase and induces apoptosis following reperfusion.
6-8) 
Anti-oxidant treatments have been reported to prevent 
myocardial reperfusion injury.
9)10) Among the anti-oxi-
dants, alpha-lipoic acid (ALA) thiol antioxidant, has 
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been shown to preserve cardiac function during ische-
mia-reperfusion while acting as a co-factor for mito-
chondrial dehydrogenase.
11-13) Several authors have re-
ported that low-dose ALA reduces myocardial reperfu-
sion injury in vitro.
13)14) To date, however, few studies 
have reported on the effectiveness of ALA in preventing 
apoptotic myocardial reperfusion injury in vivo. 
We examined whether the administration of ALA 
prior to reperfusion therapy would reduce apoptotic re-
perfusion injury of myocytes in an ischemia-reperfusion 
rat model. 
 
Materials and Methods 
 
Experimental animals 
Healthy male Sprague-Dawley rats weighed 250-300 g 
were divided into an ALA treatment group and a control 
group. The rats in both groups received 45-minutes of 
ischemia. The infarct size of the myocardium was assessed 
45 minutes following reperfusion. Apoptosis staining, 
ROS synthesis and the activity of MAP kinase were 
assessed 10 minutes following reperfusion. To confirm 
the dose of ALA, at which the infarct size was suppressed 
most effectively, ALA 10, 25, 50 and 100 mg/kg was 
administered to the right ventricle 10 minutes prior to 
the reperfusion. The infarct size was smallest in the ALA 
25 mg/kg group. Following this, apoptosis ROS syn-
thesis and MAP kinase activity were measured in the 
ALA 25 mg/kg group. 
To induce cardiac ischemia, chloral hydrate (100 mg/ 
kg) (Merck, Germany) was injected intra-abdominally 
for anesthesia. In the supine position, the rats were fixed 
onto an experimental plate. An endotracheal tube was 
placed using a 16-G tube and ventilation provided. The 
sternum was incised and the heart exposed. The proxi-
mal part of the left anterior descending artery was ligated 
using No. 6 silk and maintained for 45 minutes. Con-
firmation of myocardial infarction was based on decreased 
movement of the left ventricle and change of the coloring 
to blue. After the indicated time, the ligated suture was 
released. Reperfusion was confirmed by the return to 
normal coloring of the left ventricle. Thereafter, the rats 
were sacrificed according to schedule. During all experi-
mental procedures, the temperature of the rats was main-
tained at 37℃ with a white lamp. 
 
The measurement of the infarct size 
To measure the infarct size based on the dose of ALA 
in all groups including: ALA 10 mg/kg (n=5), 25 mg/ 
kg (n=5), 50 mg/kg (n=5), 100 mg/kg (n=5) and the 
control group (saline 0.5 mL) (n=5), propidium iodide 
(PI) 1 mg (Sigma Chemical Co.) was injected into the 
right ventricle over 30 minutes following reperfusion. PI, 
1 mg was diluted in saline 0.5 mL. Forty five minutes 
following reperfusion, the left anterior descending artery 
was ligated again. Then, in order to differentiate between 
the ischemic and normal areas, polystyrene/divinylben-
zene fluorescence (Duke Scientific) was injected into the 
proximal part of the aorta.
15) The rats were then sacrific-
ed and stored in a -70℃ refrigerator. Thereafter, the 
samples were fixated in 4% paraformaldehyde for two 
hours. Using a vibrotom, the left ventricle was vertically 
sectioned at a thickness of 400 μm. Following this, the 
basal, middle and apical areas were selected and the in-
farct size of myocardium was measured using a polarized 
microscope. On polarized microscopy, the normal area 
was observed as a green color, the ischemic area was black 
and the infarct area was a red color. The infarct size was 
defined as the ratio of the infarct area relative to the is-
chemic area of the myocardium. 
 
The measurement of apoptosis 
To measure apoptosis at the myocardial infarction site, 
terminal deoxynucleotidyl transferase mediated biotin-
dUTP nick-end labeling (TUNEL) staining was perform-
ed in the ALA 25 mg/kg group (n=5) and the control 
group (n=5), using an in situ apoptosis detection kit 
(TaKaRa Shuzo Co.). The cardiac tissue was attached to 
a glass slide and rinsed with 0.01 M phosphate buffered 
saline (PBS) (pH 7.4), and then treated with proteinase 
K (20 g/mL) at room temperature for 20 minutes. The 
sample was again rinsed with PBS. To suppress peroxi-
dase activity, intrinsic peroxidase activity was blocked 
using 3% H2O2 at room temperature for 5 minutes. Fol-
lowing the rinsing, the sample was treated with a perme-
ability buffer on ice for 2-5 minutes. Fluorescein-dUTP 
(TdT+labeling safe buffer) was used for the labeling 
performed at 37℃  in an incubator for 90 minutes. Fol-
lowing rinsing, the anti-FITC HRP conjugate underwent 
antibody reaction using a 37℃ incubator. Then, the 
color was developed using DAB (5 mg/mL in Tris buf-
fer, pH 7.0) at room temperature for 10-15 minutes. The 
degree of apoptosis was then observed using a light mi-
croscope. On light microscopy, with the use of a digital 
camera, the microscopic images were converted to a 
digital format and then saved in a computer. An auto-
matic system for the imaging analysis was used to meas-
ure the number of cells that were positive for TUNEL 
staining. 
 
The measurement of reactive oxygen species ge-
neration 
To measure ROS generation, 5-(and-6)-chloromethyl-
2’,7’-dichlorodihydro-fluorescein diacetate (CM-H2DC-
FDA) (Molecular Probes Inc., Eugene, USA) 100 μg 
was directly injected into the right ventricle 10 minutes 
prior to the ligation of the left anterior descending ar-
tery in the ALA 25 mg/kg (n=5) and control groups (n= 
5). Ten minutes prior to reperfusion, ALA or saline was 
administered to the right ventricle. Ten minutes following  
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reperfusion, the rats were sacrificed and then stored in a 
-70℃  refrigerator. Thereafter, with the use of a freezing 
microtom, the left ventricle was sectioned at a thickness 
of 40 μm in the vertical direction of the long axis. Fol-
lowing this, basal, middle and apical areas were selected. 
Then, using a polarized microscope, the fluorescent de-
velopment of a clear green color was noted, which re-
flected the ROS.
16)17) The amount of ROS synthesis was 
analyzed using image pro plus in the areas of ischemic 
injury. The images of the original green-colored samples 
were converted to an 8 bit gray color. In the areas of is-
chemic injury, the values of the gray scale were averaged 
and the expression of ROS defined. The amount of ROS 
generation that was calculated in the control group was 
summed. Then, the average was defined as the amount 
of ROS expression, which was considered 100% com-
pared to the ALA 25 mg/kg group. The amount of ROS 
generation in the ALA 25 mg/kg group was obtained by 
calculating the average value of the gray scale in the areas 
of injury in each experimental animal. This value was 
calculated as a percentile compared to the values for the 
control group. 
 
The measurement of mitogen-activated protein ki-
nase activity 
Among the MAP kinases, pERK 1/2 and pJNK 1/2 
were measured in the rats after they were sacrificed in 
both the ALA 25 mg/kg (n=5) and the control groups 
(n=5) 10 minutes following reperfusion. The infarction 
area of the left ventricle was extracted and then frozen 
using liquid nitrogen. The sample was stored in a -70℃ 
refrigerator. To isolate the protein from cardiac muscle, 
the cardiac muscles were converted to a powder using 
liquid nitrogen and a grinder. The powder of cardiac 
muscle was diluted in a histolysis buffer solution (20 mM 
Tris-HCl pH 8.0, 1% NP-40, 150 mM EDTA, 10% gly-
cerol, 0.1 % beta-mercaptoethanol, 0.5 mM DTT) at a 
ratio of 1 : 5 of weight/volume, and maintained in an 
ice bath for more than an hour. Centrifugation of the 
sample was performed at 4℃ at 12,000×g for 15 
minutes. Then, the supernatant protein was harvested. 
Thereafter, using the Bradford method,
18) the protein 
concentration was quantified using a spectrophotometer 
(Beckman Co., USA). 
Protein electrophoresis was performed using sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE). The protein was mixed with a sample buffer 
(0.125 M Tris pH 6.8, 2% SDS, 25% glycerol, bromo-
phenol blue, 2-mercaptoethanol) at 100℃. The protein 
content (80 μg), which was mixed with a histolysis buf-
fer solution, underwent electrophoresis with a 12%- and 
15%-gradient. The electrophoresis was performed using 
a mini gel electrophoremeter (SE 600 Hoefer Sci. Ins), 
at 90 V for two hours. Following electrophoresis, the gel 
was stained using Coomassie brilliant blue R-250. Des-
taining was carried out with destaining solution (10% 
acetic acid and 10% methanol) and the protein bands 
were confirmed. 
With the use of protein transfer equipment (Hoefer 
Semiphor, Phamacia Bio.), the protein gels were trans-
ferred to polyvinylidene difluoride (PVDF) membranes 
of 0.45  μm in thickness (Millipore Co., USA) for two 
hours. To block the non-specific binding of primary an-
tibodies, this PVDF membrane was placed in a block-
ing buffer where Tris buffer saline (TBS) (pH 7.6) was 
dissolved in a 3% bovine serum albumin and then the 
reaction was performed for an hour. The primary anti-
body, pERK 1/2 (1：500) (Cell Signaling Technology, 
USA), was reacted overnight at 4℃ and then rinsed 
with 0.05% Tween-20-TBS (TBST) three times. There-
after, the secondary antibody, goat rabbit immunoglo-
bulin G (IgG) conjugated AP (Santa Cruz, USA), was 
diluted at a ratio of 1 : 2,000 and the reaction was per-
formed for one hour. Following rinsing with TBST, rin-
sing with alkaline phosphates (0.1 M Tris, 0.1 M NaCl, 
0.01 M MgCl2) was performed. Thus, the color was de-
veloped with NBT and BCIP. In addition, with the same 
conditions, as the controlled experiment for pERK 1/2, 
the inactive form of ERK 1/2 protein expression was ob-
served. The expression of pJNK 1/2 and JNK 1/2 were 
also observed in the same manner as ERK. 
To analyze the degree of the expression of pERK 1/2 
and pJNK 1/2, on Western blot analysis, with the use of 
a scanner (HP4P), the pattern of the proteins’ color was 
developed on the PVDF membrane and then converted 
to a digital format. Then, the data was saved in a personal 
computer. With the use of an imaging analysis program 
(UN-SCAN-IT gel, USA), the area and density of each 
protein expression were measured. Then, these two pa-
rameters were multiplied and the volume of each protein 
was thereby calculated. The expression of active proteins, 
pERK 1/2 and pJNK 1/2, were defined based on the fi-
nal amount of expression compared to the values of 
ERK 1/2 and JNK 1/2. In addition, the relative ratio of 
expression was calculated based on the amount of ex-
pression of the active forms noted in the sham surgery 
group (n=2). 
 
Statistical analysis 
The experimental results were expressed as the mean
±standard deviation (SD). The inter-group analysis of 
the statistical data was performed using the Kruskall-
Wallis test. A value of p<0.05 was considered statistically 
significant. 
 
Results 
 
The effect of alpha-lipoic acid on the infarct size 
The infarct size based on the dose of ALA was signifi-
cantly smaller in the ALA 25 mg/kg (29.1±4.8%, p<  
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0.0001), ALA 50 mg/kg (41.5±9.5%, p<0.05), and ALA 
100 mg/kg groups (41.4±7.9%, p<0.05) compared to 
the controls (54.3±8.7%). However, the ALA 10 mg/ 
kg group (47.2±9.5%, p=0.192) did not differ signifi-
cantly from the control group. The ALA 25 mg/kg treat-
ment group had the smallest infarct size (Fig. 1) (Table 1). 
 
The effect of alpha-lipoic acid on apoptosis 
Following TUNEL staining, on light microscopy, apo-
ptotic nucleoli, which were stained as a dark brown color, 
indicating reperfusion injury due to apoptosis, were fre-
quently detected in the control group. By contrast, this 
finding was rarely seen in the ALA 25 mg/kg group (Fig. 2). 
 
The effect of alpha-lipoic acid on reactive oxygen 
species generation 
In the ALA 25 mg/kg group, the color development 
indicating the synthesis of ROS was only observed in 
41.6% (p<0.0001) compared to 100% in the control gro-
up (Fig. 3). 
 
The effect of alpha-lipoic acid on the activation of 
mitogen-activated protein kinases 
In regard to the pattern of the expression of pERK 
1/2 with regard to anti-apoptotic effects and pJNK 1/2 
with regard to apoptotic effects, the relative ratio of ex-
pression was calculated compared to the sham surgery 
group in the controls and the ALA 25 mg/kg group (Fig. 
4). The expression of pERK 1/2 was significantly incre-
ased in the ALA 25 mg/kg group compared to the control 
group as shown with pERK 1 (0.8±0.1 times vs. 1.5±
0.2 times, p<0.05) and pERK 2 (0.9±0.1 times vs. 1.6
±0.2 times, p<0.05) (Fig. 5A) (Table 2). In addition, the 
expression of pJNK 1/2 was significantly decreased in 
the ALA 25 mg/kg group compared to the control group 
as shown with pJNK 1 (2.2±0.2 times vs. 1.7±0.2 
times, p<0.05) and pJNK 2 (1.3±0.1 times vs. 1.0±0.1 
times, p<0.05) (Fig. 5B) (Table 2). 
 
Discussion 
 
In the current study, the administration of ALA prior 
to reperfusion significantly reduced the infarct size in 
rats after myocardial ischemia-reperfusion. The admini-
stration of ALA 25 mg/kg prior to reperfusion significan-
tly reduced apoptotic cell death in the myocardium. 
This anti-apoptotic effect of ALA was observed to be 
closely associated with the inhibition of ROS generation, 
the increased activity of pERK 1/2 and the decreased 
activity of pJNK 1/2. 
Prompt reperfusion is essential for the survival of car-
diac muscle after an ischemic event. In addition to the 
cardiac injury caused by ischemia, the reperfusion itself   
can promote cardiac injury and make it worse. This phe-
Table 1. Ischemic area, infarct area, and infarct size according to
ALA dose by propidium iodide fluorescence 
  Ischemic area 
(mm
2) 
Infarct area 
(mm
2) 
Infarct size* 
(%) 
Control 0.97±0.24 0.53±0.190  54.3±8.70 
ALA 10 (mg/kg)  0.95±0.27 0.45±0.200 47.2±9.50 
ALA 25 (mg/kg)  0.94±0.29 0.28±0.12
† 29.1±4.8
† 
ALA 50 (mg/kg)  0.98±0.33 0.41±0.19
‡ 41.5±9.5
‡ 
ALA 100 (mg/kg)  0.97±0.29 0.40±0.22
‡ 41.4±7.9
‡ 
*Infarct size: ratio of infarct area to ischemic area, †p<0.0001, ‡
p<0.05 compared with control. ALA: alpha-lipoic acid     
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Fig. 1. This graph shows the infarct size (ratio of infarct to ische-
mic area) according to ALA dose at 45 minutes after reperfusion
by propidium iodide fluorescence. The ALA at doses of 25 mg/
kg (p<0.0001), 50 mg/kg (p<0.05), and 100 mg/kg (p<0.05) sig-
nificantly reduced the infarct size compared to the control group,
but not the ALA 10 mg/kg (p=0.192) group. The ALA 25 mg/kg
group had the smallest infarct size. ALA: alpha-lipoic acid. 
A 
B 
Fig. 2. Light microscopic findings of TUNEL staining in the infarct
area at 10 minutes after reperfusion in the control (A) and ALA 25
mg/kg (B) groups. Apoptotic nucleoli (brown spot) were frequently
detected in the control group (A). By contrast, only a few apop-
totic nucleoli were detected in the ALA 25 mg/kg group (B). TUNEL:
terminal deoxynucleotidyl transferase-mediated biotin-dUDP nick
end labeling, ALA: alpha-lipoic acid.  
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nomenon is referred to as reperfusion injury.
1) In myo-
cardial ischemia-reperfusion, the myocardial injury is 
caused by necrosis and apoptosis. Kajstura et al.
19) and 
Fliss et al.
20) reported that myocardial injury caused by 
apoptosis was significantly more prevalent than injury 
due to necrosis in a 2-hour ischemia model and a 45-
minute ischemia and a 1-hour reperfusion model. Sev-
eral investigators have reported that apoptosis was a more 
critical factor than necrosis with regard to myocardial 
injury in ischemia-reperfusion animal models, and that 
apoptosis was significantly increased by reperfusion.
2-4) 
The exact mechanisms underlying myocardial reper-
fusion injury is not known. However, ROS are formed 
in excessive amounts within the first few minutes fol-
lowing reperfusion and are considered a major factor 
involved in myocardial reperfusion injury.
5)21-23) To mi-
nimize reperfusion injury, powerful antioxidants have 
been administered to reduce ROS generation and the-
reby decrease myocardial injury.
17)24)25) Among the antio-
xidants, ALA, a thiol compound, is a cofactor for mito-
chondrial dehydration enzymes. In the tissue mitochon-
dria, it is reduced to dithiol dihydrolipoic acid (DHLA), 
an effective form. DHLA has been reported to play a 
Table 2. The relative expression of pERK 1/2 and pJNK 1/2 in 
the infarct area by Western blot and densitometry analysis 
  Sham  Control  ALA 25 mg/kg 
pERK 1  1 0.8±0.1 1.5±0.2* 
pERK 2  1 0.9±0.1 1.6±0.2* 
pJNK 1  1 2.2±0.2 1.7±0.2* 
pJNK 2  1 1.3±0.1 1.0±0.1* 
*p<0.05 compared with control. ALA: alpha-lipoic acid, ERK: ex-
tracellular signal-regulated kinases, JNK: c-Jun-NH2-terminal kinases 
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Fig. 3. Confocal laser microscopic findings of fluorescence on
intracellular ROS generation detected by CM-H2DCFDA at 10 mi-
nutes after reperfusion in the control (A) and ALA 25 mg/kg (B)
groups. The fluorescence expression (bright green color) was more
frequently detected in the control group (A) than in the ALA 25
mg/kg group (B). The relative ROS generation and the relative le-
vel of CM-H2DCFDA fluorescence by confocal microscopy, was
significantly suppressed in the ALA 25 mg/kg group compared to
the control group (C). ROS: reactive oxygen species, CM-H2DC-
FDA: 5-(and-6)-chloromethyl-2’,7’-dichlorodihydro-fluorescein dia-
cetate, ALA: alpha-lipoic acid. 
Sham Control  ALA 25 mg/kg 
ERK 1: 44k Da 
ERK 2: 42k Da 
 
pERK1: 44k Da 
pERK2: 42k Da 
 
JNK1: 57k Da 
JNK2: 46.5k Da 
 
pJNK1: 57k Da 
pJNK2: 46.5k Da 
Fig. 4. The expression of mitogen-activated protein (MAP) kinase
by Western blot analysis pERK 1/2 expression was increased more
in the ALA 25 mg/kg group compared to controls. By contrast,
pJNK 1/2 expression was decreased more in the ALA 25 mg/kg
group than in controls. ALA: alpha-lipoic acid, ERK: extracellular
signal-regulated kinase, JNK: c-Jun-NH2-terminal kinase. 
Fig. 5. This graph shows the relative expression of pERK 1/2
(A) and pJNK 1/2 (B) in the infarct area by Western blot and den-
sitometry analysis. The relative density, of the Western blot analy-
sis by densitometry, was compared with the sham density. The 
relative density of pERK 1/2 was significantly increased (A), and for
pJNK 1/2 it was significantly decreased (B) in the ALA 25 mg/kg 
group compared to controls. *p<0.05 compared with control. ALA:
alpha-lipoic acid, ERK: extracellular signal-regulated kinase, JNK:
c-Jun-NH2-terminal kinase. 
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role in preserving myocardium function by normaliza-
tion of the intracellular pH, increased mitochondrial 
ATP synthesis and decreased ATP hydrolysis in the sett-
ing of myocardial ischemia-reperfusion.
12)13) According 
to Schonheit et al.
13) a low-dose of ALA improved cardiac 
function following reperfusion in an in vitro study. By 
contrast, a high-dose of ALA increased cardiac damage 
following reperfusion. Based on these findings, the ef-
fect of ALA treatment on the prevention of reperfusion 
injury was thought to be dose-dependent. According to 
Cao et al.
14) a minimal dose of ALA increased intrinsic 
antioxidants and the concentration of phase 2 enzymes 
with defense against oxidation, in an experiment using 
cultured cardiac cells from rats. Thus, ALA has been re-
ported to reduce myocardial injury caused by ROS. 
ALA has been reported to prevent ischemia-reperfu-
sion injury in a dose-dependent manner in vitro. To 
date, however, few studies have examined the effects of 
ALA on the prevention of myocardial ischemia-reperfu-
sion injury in vivo. In the current study, the infarct size 
of the myocardium was differentially suppressed depend-
ing on the dose of ALA administered 10 minutes prior 
to reperfusion. Compared to the control group, the ALA 
25 mg/kg group (p<0.0001) had the smallest infarct size. 
In addition, the infarct size was also suppressed in the 
50 mg/kg (p<0.05) and the 100 mg/kg groups (p<0.05). 
However, the infarct size was not significantly sup-
pressed in the ALA 10 mg/kg group. Furthermore, in 
the ALA 25 mg/kg group compared to the control group, 
apoptosis was significantly suppressed. These results in-
dicate that ALA suppressed apoptosis and reduced myo-
cardial injury during reperfusion. 
Little is known about the mechanisms that cause myo-
cardial injury due to apoptosis as a result of ischemia-
reperfusion in the myocardium. Immediately after reper-
fusion, however, an excessive degree of ROS generation 
and the activation of MAP kinase might be involved. 
ROS generation reached the highest levels within a mi-
nute following reperfusion and thereafter persisted. An 
excessive degree of ROS generation is known to play a 
crucial role in the pathogenesis of myocardial injury due 
to apoptosis immediately after reperfusion.
21-23) The ROS 
can be synthesized from endothelial cells, inflammatory 
cells and cardiac cells through a variety of enzyme activity. 
Particularly in the early stage of reperfusion, an excessive 
amount of ROS generation in the endothelial cells and 
cardiac cells stimulates inflammatory cells and the acti-
vated inflammatory cells release ROS. Thus, ROS plays 
a key role in the early and late stages of apoptosis.
22)26)27) 
ROS generation reached maximum levels within a min-
ute following reperfusion. Therefore, to minimize the 
reperfusion injury, antioxidant treatment must be per-
formed prior to reperfusion. 
Bolli et al.
23) assessed myocardial contractility in groups 
where treatment was performed 15 and 1 minute prior 
to reperfusion and 1 minute following reperfusion with 
a control group in a canine myocardial ischemia-reper-
fusion model. In the groups where the treatment was 
performed 15 and 1 minute prior to reperfusion, com-
pared to the control group, the myocardial contractility 
was significantly improved. In the group where the treat-
ment was performed 1 minute following reperfusion, 
however, there was no significant difference between the 
treated and control groups. The investigators concluded 
that treatment must be performed prior to reperfusion 
to prevent reperfusion injury. In the current study, ALA 
was administered 10 minutes prior to reperfusion. On 
polarized light microscopy, using a detector for active 
oxygen, CM-H2DCFDA, in the ALA 25 mg/kg group 
compared to the control group, showed that the genera-
tion of ROS was significantly suppressed at the site of 
myocardial infarction (p<0.0001). These findings suggest 
that the cardioprotective effects of ALA might be closely 
associated with the suppression of apoptosis due to dec-
reased generation of ROS. 
It is not known whether ROS is involved in the acti-
vation of the protein kinase pathway, which is associated 
with the induction of apoptosis following myocardial is-
chemia and reperfusion. An excessively produced ROS 
during the early stages of reperfusion activates the in-
flammatory cells and augments the intracellular calcium 
levels. In addition, it increases the secretion of pro-apo-
ptotic genes and activates MAP kinase, nuclear factor-
κB (NF-κB) and tumor necrosis factor-α  (TNF-α), 
and thereby induces apoptosis. Thus, it is involved in 
triggering myocardial injury.
28) Protein kinase pathways 
that are activated by ischemiareperfusion of the myocar-
dium include MAP kinase, PI-3 kinase/Akt and tyrosine 
kinase. MAP kinases can be divided into three types in-
cluding the extracellular signal-regulated kinase (ERK 
1/2), c-Jun-NH2-terminal kinase 1/2 (JNK 1/2) and 
the p38 α/β kinase.
7) MAP kinase belongs to a class 
of serinethreonine protein kinases that are activated in 
response to the various stimuli. ERK 1/2 is involved in 
the survival of cells and JNK 1/2 is involved in apop-
tosis; thus, it is involved in maintaining the balance bet-
ween survival and apoptosis.
29)30) According to Yue et 
al.,
29) in a myocardial ischemia-reperfusion rat model, 
the activation of ERK 1/2 reached the highest levels 10 
minutes following ischemia and in 10 minutes following 
reperfusion. When PD98059 selectively blocked the 
ERK 1/2 pathway, the degree of apoptosis in the myo-
cardium was significantly higher compared to controls. 
Thus, it was demonstrated that pERK 1/2 has anti-
apoptotic effects in myocardial ischemia-reperfusion. In 
addition, Ferrandi et al.
30) reported that the size of the 
infarction site was decreased and the apoptosis of cardiac 
muscles was markedly reduced after activation of the JNK 
1/2 pathway was blocked following the use of AS601245, 
a JNK 1/2 inhibitor, in a myocardial ischemia-reperfu- 
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sion rat model. Thus, it was demonstrated that pJNK 
1/2 was involved in the apoptosis of myocardial ische-
mia-reperfusion. These findings suggest novel treatment 
modalities that increase pERK 1/2 involved in cell sur-
vival and suppress pJNK 1/2 involved in apoptosis; mo-
dulation of these factors might prevent myocardial re-
perfusion injury due to apoptosis. In the current study, 
the administration of ALA 25 mg/kg prior to reperfusion 
resulted in significantly increased pERK 1/2 activity 10 
minutes following reperfusion (p<0.05) compared to 
controls. In addition, the activity of pJNK 1/2 was sig-
nificantly decreased (p<0.05). These findings suggest that 
the cardioprotective effects of ALA treatment prior to 
reperfusion were closely associated with the suppression 
of apoptosis due to increased pERK 1/2 and decreased 
pJNK 1/2. 
In conclusion, the results of this study show that ALA 
therapy prior to reperfusion significantly reduced the in-
farct size in a myocardial ischemiareperfusion rat model. 
The cardioprotective effects of ALA might be associated 
with the anti-apoptotic effects of ALA. The anti-apopto-
tic effects of ALA were closely associated with the in-
hibition of ROS generation, increased activity of pERK 
1/2 and decreased activity of pJNK 1/2. The cardiopro-
tective effects of ALA with regard to reperfusion injury 
in vivo suggest that ALA therapy might be a novel treat-
ment modality for minimizing reperfusion injury in pa-
tients with acute myocardial infarction in the clinical 
setting. Additional studies are needed to examine the ef-
fects of ALA administration in a large series of patients 
with acute myocardial infarction. 
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